5 Best Low Price Pharma Stocks To Invest In

2. Viatris Inc. (NASDAQ:VTRS)

Number of Hedge Fund Investors In Q4 2023: 43

Share Price: $11.32

Viatris Inc. (NASDAQ:VTRS) is a diversified pharmaceutical company that makes and sells both specialty and generic drugs. It started off April 2024 on a strong note when a court allowed it to challenge pharma giant JNJ’s Schizophrenia treatment patent.

During last year’s fourth quarter, 43 out of the 933 hedge funds part of Insider Monkey’s database had invested in the firm. Viatris Inc. (NASDAQ:VTRS)’s largest investor among these is James E. Flynn’s Deerfield Management due to its $215 million investment.

Follow Viatris Inc